These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 30084744)

  • 21. Computed tomography-guided percutaneous cryoablation of T1b renal tumors: safety, functional and oncological outcomes.
    Grange R; Tradi F; Izaaryene J; Daidj N; Brunelle S; Walz J; Gravis G; Piana G
    Int J Hyperthermia; 2019; 36(1):1065-1071. PubMed ID: 31648584
    [No Abstract]   [Full Text] [Related]  

  • 22. Percutaneous Cryoablation of Renal Cell Carcinoma with Sinus Vein Involvement Based on Preprocedural Imaging.
    Atwell TD; Kurup AN; Boorjian SA; Schmitz JJ; Thompson RH; Leibovich BC; Schmit GD
    J Vasc Interv Radiol; 2017 Dec; 28(12):1651-1657. PubMed ID: 29042169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center.
    Cernic S; Marrocchio C; Ciabattoni R; Fiorese I; Stacul F; Giudici F; Rizzo M; Cova MA
    Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33804740
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety and efficacy of CT-guided percutaneous cryoablation for renal cell carcinoma.
    Georgiades CS; Hong K; Bizzell C; Geschwind JF; Rodriguez R
    J Vasc Interv Radiol; 2008 Sep; 19(9):1302-10. PubMed ID: 18725093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal cryoablation of small renal masses: a Korea University experience.
    Kim HK; Pyun JH; Kim JY; Kim SB; Cho S; Kang SG; Lee JG; Kim JJ; Cheon J; Kang SH
    Korean J Urol; 2015 Feb; 56(2):117-24. PubMed ID: 25685298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Oncologic Outcomes of Magnetic Resonance Imaging-Guided Cryoablation of Renal Cell Carcinoma: A 10-Year Single-Center Experience.
    Cazzato RL; De Marini P; Leonard-Lorant I; Leclerc L; Auloge P; Tricard T; Dalili D; Garnon J; Lang H; Gangi A
    Invest Radiol; 2021 Mar; 56(3):153-162. PubMed ID: 32897930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
    Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
    BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryoablation vs. radiofrequency ablation for small renal masses.
    Pirasteh A; Snyder L; Boncher N; Passalacqua M; Rosenblum D; Prologo JD
    Acad Radiol; 2011 Jan; 18(1):97-100. PubMed ID: 20880723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective analysis of the safety and efficacy of percutaneous cryoablation for pT1NxMx biopsy-proven renal cell carcinoma.
    Rodriguez R; Cizman Z; Hong K; Koliatsos A; Georgiades C
    Cardiovasc Intervent Radiol; 2011 Jun; 34(3):573-8. PubMed ID: 20628879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal Function After CT-Guided Cryoablation of Small Renal Tumours in Patients with Solitary Kidney: An Analysis of European Multinational Prospective EuRECA Registry.
    Pietersen PI; Stougaard S; Keeley FX; Lagerveld B; Breen D; King A; Nielsen TK; van Strijen M; Garnon J; Alcorn D; de Kerviler E; Zondervan P; Wah TM; Junker T; Graumann O
    Cardiovasc Intervent Radiol; 2024 May; 47(5):583-589. PubMed ID: 38273129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes of CT-guided percutaneous cryoablation of T1a and T1b renal cell carcinoma.
    Spiliopoulos S; Marzoug A; Ra H; Arcot Ragupathy SK
    Diagn Interv Radiol; 2021 Jul; 27(4):524-528. PubMed ID: 34313238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous Microwave Ablation Versus Robot-Assisted Partial Nephrectomy for Stage I Renal Cell Carcinoma: A Propensity-Matched Cohort Study Focusing Upon Long-Term Follow-Up of Oncologic Outcomes.
    Chlorogiannis DD; Kratiras Z; Efthymiou E; Moulavasilis N; Kelekis N; Chrisofos M; Stravodimos K; Filippiadis DK
    Cardiovasc Intervent Radiol; 2024 May; 47(5):573-582. PubMed ID: 38561521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study.
    Nielsen TK; Lagerveld BW; Keeley F; Lughezzani G; Sriprasad S; Barber NJ; Hansen LU; Buffi NM; Guazzoni G; van der Zee JA; Ismail M; Farrag K; Emara AM; Lund L; Østraat Ø; Borre M
    BJU Int; 2017 Mar; 119(3):390-395. PubMed ID: 27488479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative lipiodol marking and its role on survival and complication rates of CT-guided cryoablation for small renal masses.
    Hongo F; Yamada Y; Ueda T; Nakmura T; Naya Y; Kamoi K; Okihara K; Ichijo Y; Miki T; Yamada K; Ukimura O
    BMC Urol; 2017 Jan; 17(1):10. PubMed ID: 28100214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of Computed Tomography-guided Percutaneous Renal Cryoablation Under Local Anesthesia: A Single Center Experience in Taiwan.
    Lin YT; Hung SW; Liu MC; Chiu KY; Chai JW; Lin JC
    Anticancer Res; 2023 Apr; 43(4):1699-1708. PubMed ID: 36974775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation.
    Bang HJ; Littrup PJ; Goodrich DJ; Currier BP; Aoun HD; Heilbrun LK; Vaishampayan U; Adam B; Goodman AC
    J Vasc Interv Radiol; 2012 Jun; 23(6):770-7. PubMed ID: 22538119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous Cryoablation of Stage T1b Renal Cell Carcinoma: Safety, Technical Results, and Clinical Outcomes.
    Gunn AJ; Joe WB; Salei A; El Khudari H; Mahmoud KH; Bready E; Keasler EM; Patten PP; Gordetsky JB; Rais-Bahrami S; Abdel Aal AK
    Cardiovasc Intervent Radiol; 2019 Jul; 42(7):970-978. PubMed ID: 31044292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients.
    Zhou W; Herwald SE; Uppot RN; Arellano RS
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1743-1750. PubMed ID: 29721615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.
    Haddad MM; Schmit GD; Kurup AN; Schmitz JJ; Boorjian SA; Geske J; Thompson RH; Callstrom MR; Atwell TD
    J Vasc Interv Radiol; 2018 Aug; 29(8):1122-1126. PubMed ID: 29887184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.